Multimodality therapy in gastric cancer

Usha Malhotra, Mei Ka Fong

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Gastric cancer remains a significant cause of morbidity and mortality worldwide. Surgical resection has been the mainstay of curative therapy for localized and locoregional disease, but high local and distant recurrence rates have led to evaluation of additional therapies. A number of trials have evaluated chemotherapy and/or radiation both in the neoadjuvant and adjuvant settings as additional modalities to improve outcome after surgical resection. Though there is consensus that additional modalities play a role in improving overall survival after curative intent surgery, preference for certain regimens and modalities varies markedly across different regions of the world.

Original languageEnglish (US)
Title of host publicationMinimally Invasive Foregut Surgery for Malignancy
Subtitle of host publicationPrinciples and Practice
PublisherSpringer International Publishing
Pages105-117
Number of pages13
ISBN (Electronic)9783319093420
ISBN (Print)9783319093413
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Multimodality therapy in gastric cancer'. Together they form a unique fingerprint.

Cite this